Medidata Expands Agreement With Worldwide Clinical Trials
Expanded relationship will utilize Medidata’s artificial intelligence solutions.
Medidata and Worldwide Clinical Trials have announced an expansion of their existing relationship. The new agreement will implement Medidata AI, enabling Worldwide to further reduce trial timelines and improve site selection.1
“Worldwide will accelerate clinical research and advance the life sciences industry by leveraging site-level granularity and real-time actionable observations provided by Medidata AI’s turnkey solution,” Tom Doyle, chief technology officer, Medidata, said in a press release.
"For over 10 years, we’ve partnered with Medidata to help our customers gather advanced, data-driven insights so they can make confident and well-informed decisions about the future direction of their clinical trials,” Peter Benton, president and CEO, Worldwide Clinical Trials said in the press release. “Incorporating Medidata AI Intelligent Trials into our studies will allow us to more systematically plan, design, and execute research so we can deliver a better experience for patients and sponsors.”
Medidata AI appeared in the news earlier this year as well, when Medidata renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc. A key element of this collaboration is the evolution of PPD TrueCast, a business solution powered by Medidata AI, which combines patient recruitment and site performance data to deliver predictive models and advanced analytics.2
In addition to Medidata AI, the new agreement with PPD featured the Medidata Platform, Medidata Adjudicate, and additional Medidata Rave product offerings. The duo has been working together on clinical studies for biopharmaceutical and medical device companies since 2009.
References
1. Medidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience. News release. May 14, 2024. Accessed May 14, 2024. https://www.3ds.com/newsroom/press-releases/medidata-selected-worldwide-clinical-trials-accelerate-trials-and-transform-patient-experience
2. Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation. News release. February 28, 2024. Accessed May 14, 2024. https://www.medidata.com/en/about-us/news-and-press/medidata-and-thermo-fisher-scientifics-ppd-clinical-research-business-collaborate-to-accelerate-clinical-trials-innovation/
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
